{"gene":"GSX2","run_date":"2026-06-10T01:55:21","timeline":{"discoveries":[{"year":1995,"finding":"Gsh-2 encodes a homeodomain protein with an Antennapedia-type homeodomain; a random oligonucleotide selection/PCR amplification procedure defined the target DNA binding sequence as CNAATTAG, establishing its biochemical activity as a sequence-specific DNA-binding transcription factor.","method":"Random oligonucleotide selection and PCR amplification (SELEX-type assay)","journal":"Mechanisms of development","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro DNA-binding assay defining binding sequence, single lab, single method","pmids":["7619729"],"is_preprint":false},{"year":1997,"finding":"Targeted loss-of-function mutation of Gsh-2 in mice results in a reduced lateral ganglionic eminence, absence of the area postrema, malformed nucleus tractus solitarius, and loss of Dlx2 expression in the LGE, demonstrating that Gsh-2 is required for proper patterning of forebrain and hindbrain structures.","method":"Targeted gene knockout in mouse; in situ hybridization; immunohistochemistry","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Strong — germline KO with defined structural and molecular phenotypes, replicated in subsequent studies","pmids":["9398437"],"is_preprint":false},{"year":2000,"finding":"Gsh2 is required to maintain the molecular identity of early striatal progenitors; in Gsh2 loss-of-function mutants, ventral telencephalic regulators Mash1 and Dlx are lost and dorsal regulators Pax6, Neurogenin1, and Neurogenin2 are ectopically expressed in the striatal germinal zone. Genetic epistasis using Pax6;Gsh2 double mutants demonstrated that Pax6 and Gsh2 govern opposing transcriptional programs and mutually repress each other's expression.","method":"Single and double loss-of-function mouse mutants; in situ hybridization; genetic epistasis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis with double-mutant rescue, multiple molecular markers, replicated across labs","pmids":["11003836"],"is_preprint":false},{"year":2000,"finding":"Gsh2 is a downstream transcriptional target of Sonic hedgehog signaling in the ventral telencephalon, and its loss results in expansion of dorsal telencephalic markers into the LGE and defects in distinct striatal neuron subpopulations and delay in GABAergic interneuron appearance in the olfactory bulb.","method":"Mouse knockout analysis; in situ hybridization; genetic epistasis","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO with defined molecular phenotype and Shh pathway placement, single lab","pmids":["11060228"],"is_preprint":false},{"year":2001,"finding":"In Gsh2 mutants, the dorsal LGE is respecified into a ventral pallium-like structure, while in Pax6 mutants the ventral pallium is respecified into a dLGE-like structure; the early overlapping expression of Pax6 and Gsh2 at the PSB and their complementary loss-of-function phenotypes establish cross-repressive patterning roles at the pallial/subpallial boundary.","method":"Analysis of Gsh2 and Pax6 single loss-of-function mouse mutants; in situ hybridization","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — independent replication of cross-repression finding across multiple labs","pmids":["11124115"],"is_preprint":false},{"year":2001,"finding":"Gsh1 compensates for loss of Gsh2 in LGE progenitors; Gsh1 expression expands in Gsh2 null LGE, and Gsh1/2 double mutants show more severe LGE molecular identity disruptions than Gsh2 single mutants. Both Gsh genes together control the size of LGE precursor pools, particularly the subventricular zone population.","method":"Single and double homozygous knockout mouse mutants; in situ hybridization","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic epistasis double-mutant analysis with clear dose-dependent phenotype","pmids":["11731457"],"is_preprint":false},{"year":2003,"finding":"Gsh2 and Nkx2.1 act cooperatively (not cross-repressively) to pattern the ventral telencephalon, as shown by double-mutant analysis. However, Gsh2 expressed in the medial ganglionic eminence after E10.5 negatively regulates Nkx2.1-dependent oligodendrocyte specification, based on loss- and gain-of-function analysis.","method":"Double-mutant mouse analysis (loss-of-function and gain-of-function); in situ hybridization","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis with double mutants and gain-of-function, single lab","pmids":["12930780"],"is_preprint":false},{"year":2004,"finding":"Gsh2 is required for expression of the retinoic acid synthesis enzyme Raldh3 (Aldh1a3) in the LGE; Gsh2 mutants show markedly reduced retinoid production (measured by retinoid reporter cell assay), and this reduced retinoid production contributes to striatal differentiation defects including fewer DARPP-32 neurons. Exogenous retinoic acid supplementation during neurogenesis significantly increases DARPP-32 expression in Gsh2 mutants.","method":"Mouse knockout; retinoid reporter cell assay; in situ hybridization; retinoic acid rescue experiment in vivo","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO phenotype confirmed by reporter assay and RA rescue experiment, multiple orthogonal methods","pmids":["15269172"],"is_preprint":false},{"year":2005,"finding":"In the dorsal spinal cord, Gsh2 is expressed in dI3, dI4, and dI5 progenitors; Gsh2 loss-of-function leads to selective loss of dI3 interneurons with expansion of the dI2 domain and downregulation of Mash1. Overexpression of Gsh2 and Mash1 together ectopically produces dI3 neurons and represses Ngn1, establishing that Gsh2 promotes dI3 fate by repressing Ngn1 and promoting Mash1 expression.","method":"Mouse knockout; in situ hybridization; gain-of-function overexpression in neural tube; genetic epistasis with Mash1 mutants","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — KO, GOF, and epistasis with multiple markers, independent validation in same study","pmids":["15930101"],"is_preprint":false},{"year":2009,"finding":"Gsx2 specifies striatal projection neuron identity when expressed at early stages of telencephalic neurogenesis, whereas delayed activation exclusively promotes olfactory bulb interneuron identity; conditional temporal inactivation of Gsx2 causes defects restricted to olfactory bulb interneurons without affecting striatal neurogenesis, demonstrating distinct temporal requirements for these two cell fate decisions.","method":"Temporally regulated transgenic gain-of-function; conditional loss-of-function (tamoxifen-inducible Cre); mouse knockout; histological analysis","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Strong — complementary GOF and conditional LOF with temporal control, multiple neuronal subtype readouts","pmids":["19709628"],"is_preprint":false},{"year":2010,"finding":"In Xenopus, Gsh2 mediates transcriptional repression of Dbx1 (identified as a direct target), and cross-repressive interactions between Gsx, Dbx, and Nkx transcription factors pattern the medial CNS at open neural plate stages; the unidirectional interaction hierarchy seen in Drosophila is not conserved in Xenopus.","method":"Gain- and loss-of-function manipulation in Xenopus; reporter assays; in situ hybridization","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct target identification with reporter assay, cross-species functional analysis, single lab","pmids":["20610487"],"is_preprint":false},{"year":2012,"finding":"Gsx2 is required for expression of the Helios transcription factor in striatal matrix neurons of the LGE; Helios expression is absent in Gsx2 null mutants but maintained in Ascl1 mutants, placing Gsx2 (together with Dlx1/2) upstream of Helios in an Ascl1-independent striatal progenitor lineage.","method":"Immunofluorescence; mouse knockout analysis (Gsx2 null, Dlx1/2 null, Ascl1 null); in situ hybridization","journal":"Stem cells and development","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — epistasis with multiple mutants, single lab","pmids":["22142223"],"is_preprint":false},{"year":2013,"finding":"Gsx2 controls region-specific activation of neural stem cells (NSCs) in the adult subventricular zone (SVZ); it is expressed in a regionally restricted NSC subset, promotes NSC activation and lineage progression to produce selective olfactory bulb neuron subtypes, and is ectopically induced after brain injury to mediate injury-induced neurogenesis.","method":"Mouse conditional knockout; immunohistochemistry; BrdU labeling; injury model; lineage tracing","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 / Strong — conditional KO with multiple cellular phenotype readouts, injury model, multiple orthogonal methods","pmids":["23723414"],"is_preprint":false},{"year":2013,"finding":"Gsx2 suppresses oligodendrocyte precursor cell (OPC) specification in dLGE progenitors; its conditional loss increases OPCs with a concomitant decrease in neurogenesis in the LGE SVZ (E12.5–15.5), and Ascl1 is required for the expansion of these dLGE-derived OPCs in the cortex of Gsx2 mutants. Gain-of-function at late embryonic stages decreases cortical OPCs, confirming that Gsx2 downregulation is required for the neurogenesis-to-oligodendrogenesis transition.","method":"Conditional gain-of-function and loss-of-function transgenic mouse; Olig2-Cre conditional inactivation; cell counting; in situ hybridization","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — complementary conditional GOF and LOF, lineage-specific Cre, Ascl1 epistasis, multiple readouts","pmids":["23637331"],"is_preprint":false},{"year":2013,"finding":"Gsx2 loss-of-function rescues overexpression of Ascl1, Hes5, and Olig2 in Dlx1/2 mutants; double Dlx1/2;Gsx2 mutants exacerbate LGE/CGE/septum patterning defects including loss of GAD1 expression; Gsx1 loss from Dlx1/2 mutants partially rescues MGE interneuron migration. These epistasis results place Gsx2 downstream of Dlx1/2 in controlling Ascl1/Notch signaling in the LGE.","method":"Compound loss-of-function mouse mutants; in situ hybridization; immunohistochemistry; genetic epistasis","journal":"The Journal of comparative neurology","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple compound mutant combinations defining pathway position, multiple molecular readouts","pmids":["23042297"],"is_preprint":false},{"year":2018,"finding":"DMRT3, DMRT5, and EMX2 cooperatively repress Gsx2 at the pallium-subpallium boundary; all three transcription factors directly bind a ventral telencephalon-specific enhancer in the Gsx2 locus (shown by ChIP/binding assays), and loss of Dmrt3;Dmrt5 upregulates Gsx2 in dorsal telencephalon while ectopic Dmrt5 downregulates it ventrally.","method":"Single and double knockout mouse mutants; gain-of-function electroporation; ChIP/transcription factor binding assay on Gsx2 enhancer; in situ hybridization","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct enhancer binding demonstrated, multiple KO combinations, GOF/LOF concordance","pmids":["30143575"],"is_preprint":false},{"year":2019,"finding":"Recessive loss-of-function variants in human GSX2 (a truncating p.S9* variant causing complete loss of protein, and a missense p.Q251R variant in the homeodomain) cause basal ganglia agenesis. The Q251R missense variant results in reduced protein expression, impaired homeodomain structural stability, weaker DNA interaction (molecular dynamics), reduced nuclear localization in transfected cells, and altered transcriptional self-regulation with downstream changes in ASCL1 and PAX6 expression in patients' fibroblasts.","method":"Whole-exome sequencing; western blot; transfection/nuclear localization assay; molecular dynamics simulation; fibroblast expression studies; whole transcriptome analysis","journal":"Brain : a journal of neurology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — human variant functional characterization, multiple methods but molecular dynamics is computational; nuclear localization directly tested","pmids":["31412107"],"is_preprint":false},{"year":2020,"finding":"Gsx2 gains DNA-binding specificity by forming cooperative homodimers on precisely spaced and oriented bipartite DNA sites; high-resolution genomic binding (ChIP) shows Gsx2 occupies both monomer and homodimer sites in the developing mouse ventral telencephalon. Reporter assays demonstrate that monomer Gsx2 binding represses transcription whereas homodimer binding stimulates gene expression, defining an opposing regulatory outcome dependent on binding site configuration and protein level.","method":"High-resolution genomic binding (ChIP-seq); luciferase reporter assays; in vivo Drosophila reporter assays; biochemical DNA-binding assays","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — ChIP-seq, in vitro biochemical assays, in vivo reporter assays, cross-species validation, multiple orthogonal methods","pmids":["33334823"],"is_preprint":false},{"year":2020,"finding":"Gsx2 physically interacts with the bHLH domain of Ascl1, interfering with Ascl1's ability to bind DNA; co-expression of Gsx2 with Ascl1 inhibits neurogenesis in a dose-dependent and Gsx2 DNA-binding-independent manner. Proximity ligation assay in tissue sections demonstrated that Ascl1-Gsx2 interactions are enriched in LGE ventricular zone progenitors, while Ascl1-Tcf3 interactions predominate in the SVZ.","method":"Co-immunoprecipitation; luciferase reporter assays; DNA-binding assays; proximity ligation assay in tissue sections; misexpression in dorsal telencephalic progenitors","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — direct protein-protein interaction shown by Co-IP, DNA-binding interference assay, in situ PLA, functional reporter assays, multiple orthogonal methods","pmids":["32122989"],"is_preprint":false},{"year":2020,"finding":"Gsx2 is required for normal forebrain patterning and long-term survival in zebrafish; gsx2 null mutants show significantly reduced expression of distal-less homeobox forebrain patterning genes and fail swim bladder inflation, preventing survival to adulthood.","method":"TALEN-mediated zebrafish knockout; in situ hybridization; survival analysis","journal":"Developmental dynamics","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — KO with molecular phenotype in zebrafish model, single lab","pmids":["36184733"],"is_preprint":false},{"year":2020,"finding":"In zebrafish, gsx2 is required for specification of inferior olivary nucleus (IO) neurons from ptf1a-expressing neural progenitors; gsx2 mutants show strong reduction/loss of IO neurons. Retinoic acid signals positively regulate gsx2 expression and IO neuron development, while Fgf3 and Fgf8a negatively regulate gsx2 expression, placing gsx2 as a mediator of positional signals for IO identity.","method":"Zebrafish mutant analysis; in situ hybridization; pharmacological manipulation of RA and FGF signaling","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — KO phenotype with epistasis and signaling pathway placement, single lab, zebrafish model","pmids":["32928905"],"is_preprint":false},{"year":2024,"finding":"Crystal structure of Gsx2 homeodomain bound to DNA revealed that Gsx2 is a monomer in solution and requires DNA for cooperative complex formation; Gsx2 induces a 20° bend in DNA upon binding; a specific protein-protein interface was identified that is required for cooperative homodimerization on DNA; flexible spacer sequences enhance cooperativity on dimer sites. Thermodynamic binding parameters for Gsx2/DNA interactions were defined.","method":"X-ray crystallography (high-resolution monomer/DNA structure); biochemical binding assays; biophysical characterization (ITC/SPR); mutagenesis of protein-protein interface","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 / Strong — crystal structure plus mutagenesis plus biophysical assays, multiple orthogonal methods in single rigorous study","pmids":["38874471"],"is_preprint":false},{"year":2025,"finding":"The Gsx2Q252R variant (modeling human GSX2Q251R) selectively alters DNA binding; mice carrying this allele exhibit basal ganglia dysgenesis (hypomorphic relative to null), survive to birth with relative sparing of glutamatergic nTS neurons and catecholaminergic A1/C1 and A2/C2 groups, demonstrating that distinct thresholds of Gsx2 DNA-binding activity are required for different neuronal subtypes.","method":"Knock-in mouse model; biochemical DNA-binding assays; histological and immunofluorescence analysis; comparison to Gsx2 null mice","journal":"Disease models & mechanisms","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — biochemical assay confirming selective DNA-binding defect, in vivo hypomorphic phenotype, comparison to null, multiple neuronal readouts","pmids":["39882631"],"is_preprint":false},{"year":2025,"finding":"Mutant IDH promotes promoter hypermethylation and silencing of Gsx2 in neural progenitor cells, mediating lineage switching from interneuron to oligodendrocyte precursor cell fate; Gsx2 ablation alone recapitulates this NPC fate reprogramming, demonstrating Gsx2 as a required mediator of IDH-mutant glioma initiation.","method":"Genetically engineered mouse models; time-resolved single-cell genomics; Gsx2 conditional ablation; epigenomic analysis","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — conditional KO recapitulates oncogene phenotype, single-cell genomics, preprint not yet peer-reviewed","pmids":["40832272"],"is_preprint":true},{"year":2026,"finding":"In human LGE-like progenitors derived from hESCs with inducible GSX2 expression, transcriptomic/chromatin accessibility/genomic binding studies showed that GSX2 binds both high- and low-accessibility chromatin with varying site preferences, alters chromatin accessibility largely through indirect mechanisms, functions primarily as a transcriptional repressor, and regulates conserved target genes affecting neuronal progenitor maturation and regional specification.","method":"Dox-inducible hESC system; RNA-seq; ATAC-seq; ChIP-seq/genomic binding assays","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — multi-omics with transcriptomic, chromatin accessibility and direct genomic binding data, multiple orthogonal methods in human model system","pmids":["41512913"],"is_preprint":false},{"year":2026,"finding":"In zebrafish spinal cord, Gsx2 is expressed in pre-OPC progenitors and restrains the timing of OPC specification; gsx2 CRISPR loss-of-function mutants initiate OPC formation prematurely and produce excess OPCs without altering oligodendrocyte differentiation, indicating Gsx2 suppresses premature OPC specification in the spinal cord pMN domain.","method":"CRISPR/Cas9 knockout zebrafish; single-cell RNA-seq; single-nuclei ATAC-seq; cell counting","journal":"Developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — CRISPR KO with defined cellular phenotype, multi-omics for target prediction, single lab","pmids":["41491310"],"is_preprint":false}],"current_model":"GSX2 (Gsh2) is a homeodomain transcription factor that binds DNA both as a monomer (repressing transcription) and as a cooperative homodimer on precisely spaced bipartite sites (activating transcription), inducing a 20° DNA bend; it controls dorsoventral patterning of the ventral telencephalon by cross-repressing Pax6, regulating Raldh3/retinoid production, and physically interacting with and inhibiting the bHLH factor Ascl1 to balance LGE progenitor maintenance versus neurogenesis, while also controlling the timing of OPC specification by suppressing oligodendrogenesis; its downstream target genes include Dlx, Mash1/Ascl1, Ngn1, Dbx1, Raldh3, and Helios, and loss-of-function in humans causes basal ganglia agenesis."},"narrative":{"mechanistic_narrative":"GSX2 (Gsh2) is a sequence-specific homeodomain transcription factor that governs dorsoventral patterning and cell-fate decisions in the developing ventral telencephalon and broader CNS [PMID:7619729, PMID:9398437]. It maintains the molecular identity of lateral ganglionic eminence (LGE) progenitors through mutual cross-repression with the dorsal determinant Pax6 at the pallial/subpallial boundary, where loss of Gsx2 respecifies the dorsal LGE toward a ventral pallium-like fate and derepresses Pax6, Neurogenin1/2 [PMID:11003836, PMID:11124115]. As a downstream effector of Sonic hedgehog signaling, Gsx2 acts partly redundantly with Gsh1 to set the size of striatal precursor pools [PMID:11060228, PMID:11731457], and it drives a striatal differentiation program in part by inducing the retinoic acid synthesis enzyme Raldh3/Aldh1a3, with retinoid supplementation rescuing DARPP-32 neuron deficits in mutants [PMID:15269172]. Gsx2 controls distinct fates in a temporally and dose-dependent manner: early activity specifies striatal projection neurons while delayed activity promotes olfactory bulb interneuron identity [PMID:19709628], and downregulation of Gsx2 is required to license the neurogenesis-to-oligodendrogenesis transition, with its loss producing excess OPCs both in the telencephalon and spinal cord [PMID:23637331, PMID:41491310]. Mechanistically, Gsx2 acts as a transcriptional repressor at monomeric sites but as an activator when it forms cooperative homodimers on precisely spaced bipartite DNA elements, an interaction that bends DNA ~20° and requires a defined protein–protein interface revealed by crystallography [PMID:33334823, PMID:38874471, PMID:41512913]. In parallel, Gsx2 physically binds the bHLH domain of the proneural factor Ascl1 to block its DNA binding and inhibit neurogenesis independently of Gsx2's own DNA-binding activity, thereby balancing progenitor maintenance against differentiation [PMID:32122989]. Recessive loss-of-function variants in human GSX2 cause basal ganglia agenesis, and a homeodomain missense variant modeled in mice produces a hypomorphic DNA-binding defect with selective, threshold-dependent loss of neuronal subtypes [PMID:31412107, PMID:39882631].","teleology":[{"year":1995,"claim":"Established the biochemical identity of Gsh-2 as a sequence-specific DNA-binding factor by defining its preferred target motif, the prerequisite for interpreting all subsequent genetic phenotypes as transcriptional.","evidence":"Random oligonucleotide selection/PCR (SELEX-type) defining the CNAATTAG binding sequence for the Antennapedia-type homeodomain","pmids":["7619729"],"confidence":"Medium","gaps":["In vitro binding only; no cellular target genes identified","Did not address monomer versus dimer binding modes"]},{"year":1997,"claim":"Demonstrated an in vivo developmental requirement by showing that Gsh-2 loss disrupts forebrain and hindbrain structures and abolishes Dlx2 in the LGE, moving the gene from a biochemical entity to a patterning regulator.","evidence":"Targeted gene knockout in mouse with in situ hybridization and immunohistochemistry","pmids":["9398437"],"confidence":"High","gaps":["Direct versus indirect regulation of Dlx2 not resolved","Molecular partners not identified"]},{"year":2000,"claim":"Defined the core patterning logic of the ventral telencephalon by showing Gsx2 and Pax6 occupy opposing, mutually repressive transcriptional programs and that Gsx2 is a Shh target, situating it within a signaling-to-fate axis.","evidence":"Single and double (Pax6;Gsh2) loss-of-function mouse mutants and genetic epistasis; Shh pathway placement","pmids":["11003836","11060228"],"confidence":"High","gaps":["Whether cross-repression is direct at the DNA level not shown","Mechanism of Shh-to-Gsx2 induction unresolved"]},{"year":2001,"claim":"Refined the cross-repression model to the pallial/subpallial boundary and revealed genetic redundancy, showing Gsh1 compensates for Gsh2 loss and that both genes jointly set LGE precursor pool size.","evidence":"Gsh2 and Pax6 single mutants and Gsh1/2 single/double knockouts with in situ hybridization","pmids":["11124115","11731457"],"confidence":"High","gaps":["Degree of biochemical equivalence between Gsh1 and Gsh2 unknown","Direct targets at the boundary not defined"]},{"year":2003,"claim":"Distinguished Gsx2's combinatorial logic from simple cross-repression, showing cooperative action with Nkx2.1 in patterning but negative regulation of Nkx2.1-dependent oligodendrocyte specification.","evidence":"Double-mutant loss- and gain-of-function mouse analysis with in situ hybridization","pmids":["12930780"],"confidence":"Medium","gaps":["Molecular basis of OPC suppression not defined","Single lab"]},{"year":2004,"claim":"Connected Gsx2 to a specific differentiation effector pathway by showing it is required for Raldh3-driven retinoid production, with RA rescue of striatal neuron deficits establishing a causal output.","evidence":"Mouse knockout, retinoid reporter cell assay, and in vivo retinoic acid rescue","pmids":["15269172"],"confidence":"High","gaps":["Whether Gsx2 directly binds the Raldh3 locus not shown","Other RA-dependent targets not enumerated"]},{"year":2005,"claim":"Generalized Gsx2 fate logic beyond the telencephalon to the dorsal spinal cord, defining a repress-Ngn1/promote-Mash1 mechanism for dI3 interneuron specification.","evidence":"Mouse knockout, neural tube gain-of-function, and epistasis with Mash1 mutants","pmids":["15930101"],"confidence":"High","gaps":["Direct versus indirect Ngn1 repression not resolved in this context"]},{"year":2009,"claim":"Revealed that the same factor produces different fates depending on timing, with early Gsx2 specifying striatal projection neurons and delayed activity producing olfactory bulb interneurons.","evidence":"Temporally regulated transgenic gain-of-function and tamoxifen-inducible conditional loss-of-function in mouse","pmids":["19709628"],"confidence":"High","gaps":["Molecular basis of temporal competence change not defined"]},{"year":2010,"claim":"Identified a direct transcriptional target (Dbx1) and showed the Gsx/Dbx/Nkx cross-repressive network is rewired across species, indicating the network architecture is not strictly conserved.","evidence":"Gain/loss-of-function in Xenopus with reporter assays and in situ hybridization","pmids":["20610487"],"confidence":"Medium","gaps":["Direct binding shown in reporter context only","Single lab, single non-mammalian system"]},{"year":2012,"claim":"Placed Gsx2 upstream of Helios in an Ascl1-independent striatal lineage, beginning to dissect parallel branches of the LGE progenitor program.","evidence":"Immunofluorescence and epistasis across Gsx2, Dlx1/2, and Ascl1 mutant mice","pmids":["22142223"],"confidence":"Medium","gaps":["Direct regulation of Helios not demonstrated","Single lab"]},{"year":2013,"claim":"Extended Gsx2 function to adult and injury-induced neurogenesis and clarified its role at the neurogenesis-to-oligodendrogenesis switch, embedding it in Dlx1/2 and Ascl1/Notch circuitry.","evidence":"Conditional KO, GOF, lineage tracing, injury models, and compound Dlx1/2;Gsx2 and Gsx1 epistasis in mouse","pmids":["23723414","23637331","23042297"],"confidence":"High","gaps":["Direct targets controlling OPC suppression not identified","Mechanism of injury-induced ectopic induction unknown"]},{"year":2018,"claim":"Identified upstream direct regulators of the Gsx2 locus, showing DMRT3, DMRT5, and EMX2 bind a ventral-telencephalon enhancer to confine Gsx2 expression to the subpallium.","evidence":"Single/double mouse knockouts, GOF electroporation, and ChIP/binding assays on the Gsx2 enhancer","pmids":["30143575"],"confidence":"High","gaps":["Cofactor requirements for enhancer repression not detailed"]},{"year":2019,"claim":"Established human disease causation, showing recessive truncating and homeodomain missense GSX2 variants cause basal ganglia agenesis with measurable effects on protein stability, DNA interaction, and nuclear localization.","evidence":"Whole-exome sequencing, western blot, nuclear localization assay, molecular dynamics, and patient fibroblast transcriptomics","pmids":["31412107"],"confidence":"Medium","gaps":["DNA-binding defect of missense allele inferred computationally","Patient cohort limited"]},{"year":2020,"claim":"Resolved the dual regulatory logic of Gsx2 mechanistically, showing monomer binding represses while cooperative homodimers on spaced bipartite sites activate, with binding-site configuration and protein level dictating outcome.","evidence":"ChIP-seq, luciferase and in vivo Drosophila reporter assays, and biochemical DNA-binding assays","pmids":["33334823"],"confidence":"High","gaps":["Cofactors discriminating activation versus repression in vivo not identified"]},{"year":2020,"claim":"Uncovered a DNA-binding-independent mechanism, demonstrating Gsx2 physically sequesters the Ascl1 bHLH domain to block its DNA binding and inhibit neurogenesis, with spatially distinct Ascl1 partner usage between VZ and SVZ.","evidence":"Co-immunoprecipitation, DNA-binding interference, in situ proximity ligation, and reporter/misexpression assays","pmids":["32122989"],"confidence":"High","gaps":["Stoichiometry and structural basis of the Gsx2-Ascl1 interface not defined","Reciprocal effect on Gsx2 transcriptional activity not quantified"]},{"year":2020,"claim":"Confirmed conserved patterning and identity functions in zebrafish for forebrain Dlx genes and for inferior olivary neurons, with RA promoting and FGF restraining gsx2 expression.","evidence":"TALEN and mutant zebrafish analysis with in situ hybridization and pharmacological RA/FGF manipulation","pmids":["36184733","32928905"],"confidence":"Medium","gaps":["Direct targets in zebrafish not defined","Single lab per study"]},{"year":2024,"claim":"Provided the structural basis for cooperative function, showing Gsx2 is monomeric in solution, requires DNA for homodimer assembly through a defined interface, and bends DNA ~20°.","evidence":"X-ray crystallography of homeodomain/DNA, interface mutagenesis, and ITC/SPR biophysics","pmids":["38874471"],"confidence":"High","gaps":["Full-length protein and cofactor complexes not crystallized","Link between bend and transcriptional output not directly tested"]},{"year":2025,"claim":"Linked DNA-binding activity to subtype-specific thresholds in vivo, showing a knock-in modeling the human missense variant causes hypomorphic basal ganglia dysgenesis with selective sparing of certain neuron groups.","evidence":"Knock-in mouse model with biochemical DNA-binding assays and histological comparison to null mice","pmids":["39882631"],"confidence":"High","gaps":["Locus-specific target sensitivities underlying threshold differences not mapped"]},{"year":2025,"claim":"Implicated Gsx2 silencing as a required mediator of IDH-mutant glioma initiation, showing promoter hypermethylation reprograms NPCs from interneuron to OPC fate and Gsx2 ablation recapitulates this switch.","evidence":"Genetically engineered mouse models, time-resolved single-cell genomics, conditional ablation, and epigenomics (preprint)","pmids":["40832272"],"confidence":"Medium","gaps":["Preprint not yet peer-reviewed","Direct Gsx2 targets controlling the oncogenic fate switch not defined"]},{"year":2026,"claim":"Characterized GSX2 chromatin behavior in a human progenitor system, showing it binds both accessible and inaccessible chromatin, acts mainly as a repressor, and alters accessibility largely indirectly.","evidence":"Dox-inducible hESC-derived LGE-like progenitors with RNA-seq, ATAC-seq, and ChIP-seq","pmids":["41512913"],"confidence":"High","gaps":["Mechanism of indirect chromatin remodeling unresolved","Cofactors mediating repression not identified"]},{"year":2026,"claim":"Confirmed a conserved gliogenic timing role, showing Gsx2 in zebrafish pMN pre-OPC progenitors restrains premature OPC specification without altering differentiation.","evidence":"CRISPR/Cas9 zebrafish knockout with single-cell RNA-seq and single-nuclei ATAC-seq","pmids":["41491310"],"confidence":"Medium","gaps":["Direct targets controlling OPC timing not validated","Single lab"]},{"year":null,"claim":"It remains unresolved which cofactors and locus-specific features switch Gsx2 between monomeric repression and dimeric activation in vivo, and how these determine subtype-specific thresholds and the oncogenic fate switch.","evidence":"","pmids":[],"confidence":"High","gaps":["No identified cofactor that selects activator versus repressor mode in vivo","Genome-wide direct activated versus repressed target sets not fully separated","Mechanism of indirect chromatin accessibility changes unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,2,17,24]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,17,21,22]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[18]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[16]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[1,2,9,13]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[17,24]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[8,12]}],"complexes":[],"partners":["ASCL1","PAX6","GSH1","NKX2.1","DLX1","DLX2"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q9BZM3","full_name":"GS homeobox 2","aliases":["Genetic-screened homeobox 2","Homeobox protein GSH-2"],"length_aa":304,"mass_kda":32.0,"function":"Transcription factor that binds 5'-CNAATTAG-3' DNA sequence and regulates the expression of numerous genes including genes important for brain development (PubMed:31412107). During telencephalic development, causes ventralization of pallial progenitors and, depending on the developmental stage, specifies different neuronal fates. At early stages, necessary and sufficient to correctly specify the ventral lateral ganglionic eminence (LGE) and its major derivatives, the striatal projection neurons. At later stages, may specify LGE progenitors toward dorsal LGE fates, including olfactory bulb interneurons (By similarity)","subcellular_location":"Nucleus; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q9BZM3/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GSX2","classification":"Not Classified","n_dependent_lines":6,"n_total_lines":1208,"dependency_fraction":0.004966887417218543},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GSX2","total_profiled":1310},"omim":[{"mim_id":"618646","title":"DIENCEPHALIC-MESENCEPHALIC JUNCTION DYSPLASIA SYNDROME 2; DMJDS2","url":"https://www.omim.org/entry/618646"},{"mim_id":"616253","title":"GS HOMEOBOX 2; GSX2","url":"https://www.omim.org/entry/616253"},{"mim_id":"251280","title":"DIENCEPHALIC-MESENCEPHALIC JUNCTION DYSPLASIA SYNDROME 1; DMJDS1","url":"https://www.omim.org/entry/251280"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in single","driving_tissues":[{"tissue":"brain","ntpm":1.1}],"url":"https://www.proteinatlas.org/search/GSX2"},"hgnc":{"alias_symbol":["Gsh2"],"prev_symbol":[]},"alphafold":{"accession":"Q9BZM3","domains":[{"cath_id":"1.10.10.60","chopping":"212-259","consensus_level":"high","plddt":97.8802,"start":212,"end":259}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BZM3","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BZM3-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9BZM3-F1-predicted_aligned_error_v6.png","plddt_mean":59.22},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GSX2","jax_strain_url":"https://www.jax.org/strain/search?query=GSX2"},"sequence":{"accession":"Q9BZM3","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9BZM3.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9BZM3/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9BZM3"}},"corpus_meta":[{"pmid":"11124115","id":"PMC_11124115","title":"Gsh2 and Pax6 play complementary roles in dorsoventral patterning of the mammalian telencephalon.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11124115","citation_count":389,"is_preprint":false},{"pmid":"11003836","id":"PMC_11003836","title":"Genetic control of dorsal-ventral identity in the telencephalon: opposing roles for Pax6 and Gsh2.","date":"2000","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11003836","citation_count":336,"is_preprint":false},{"pmid":"11060228","id":"PMC_11060228","title":"The Gsh2 homeodomain gene controls multiple aspects of telencephalic development.","date":"2000","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11060228","citation_count":195,"is_preprint":false},{"pmid":"15610346","id":"PMC_15610346","title":"Differential targeting of GSH1 and GSH2 is achieved by multiple transcription initiation: implications for the compartmentation of glutathione biosynthesis in the Brassicaceae.","date":"2005","source":"The Plant journal : for cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15610346","citation_count":177,"is_preprint":false},{"pmid":"11731457","id":"PMC_11731457","title":"A role for Gsh1 in the developing striatum and olfactory bulb of Gsh2 mutant mice.","date":"2001","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/11731457","citation_count":141,"is_preprint":false},{"pmid":"19709628","id":"PMC_19709628","title":"Distinct temporal requirements for the homeobox gene Gsx2 in specifying striatal and olfactory bulb neuronal fates.","date":"2009","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/19709628","citation_count":113,"is_preprint":false},{"pmid":"12930780","id":"PMC_12930780","title":"Combinatorial function of the homeodomain proteins Nkx2.1 and Gsh2 in ventral telencephalic patterning.","date":"2003","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/12930780","citation_count":100,"is_preprint":false},{"pmid":"9398437","id":"PMC_9398437","title":"Altered forebrain and hindbrain development in mice mutant for the Gsh-2 homeobox gene.","date":"1997","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/9398437","citation_count":90,"is_preprint":false},{"pmid":"7619729","id":"PMC_7619729","title":"Gsh-2, a murine homeobox gene expressed in the developing brain.","date":"1995","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/7619729","citation_count":77,"is_preprint":false},{"pmid":"23723414","id":"PMC_23723414","title":"Gsx2 controls region-specific activation of neural stem cells and injury-induced neurogenesis in the adult subventricular zone.","date":"2013","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/23723414","citation_count":76,"is_preprint":false},{"pmid":"23042297","id":"PMC_23042297","title":"Loss of Gsx1 and Gsx2 function rescues distinct phenotypes in Dlx1/2 mutants.","date":"2013","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/23042297","citation_count":65,"is_preprint":false},{"pmid":"18701439","id":"PMC_18701439","title":"Differential regulation of telencephalic pallial-subpallial boundary patterning by Pax6 and Gsh2.","date":"2008","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/18701439","citation_count":60,"is_preprint":false},{"pmid":"23637331","id":"PMC_23637331","title":"The homeobox gene Gsx2 controls the timing of oligodendroglial fate specification in mouse lateral ganglionic eminence progenitors.","date":"2013","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/23637331","citation_count":49,"is_preprint":false},{"pmid":"9512666","id":"PMC_9512666","title":"Molecular identification of glutathione synthetase (GSH2) gene from Saccharomyces cerevisiae.","date":"1998","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/9512666","citation_count":43,"is_preprint":false},{"pmid":"15930101","id":"PMC_15930101","title":"Gsh2 is required for the repression of Ngn1 and specification of dorsal interneuron fate in the spinal cord.","date":"2005","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15930101","citation_count":42,"is_preprint":false},{"pmid":"15269172","id":"PMC_15269172","title":"The homeobox gene Gsh2 is required for retinoid production in the embryonic mouse telencephalon.","date":"2004","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15269172","citation_count":38,"is_preprint":false},{"pmid":"28137879","id":"PMC_28137879","title":"Differentiation of human telencephalic progenitor cells into MSNs by inducible expression of Gsx2 and Ebf1.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28137879","citation_count":32,"is_preprint":false},{"pmid":"30143575","id":"PMC_30143575","title":"DMRT5, DMRT3, and EMX2 Cooperatively Repress Gsx2 at the Pallium-Subpallium Boundary to Maintain Cortical Identity in Dorsal Telencephalic Progenitors.","date":"2018","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30143575","citation_count":30,"is_preprint":false},{"pmid":"22142223","id":"PMC_22142223","title":"Helios transcription factor expression depends on Gsx2 and Dlx1&2 function in developing striatal matrix neurons.","date":"2012","source":"Stem cells and development","url":"https://pubmed.ncbi.nlm.nih.gov/22142223","citation_count":26,"is_preprint":false},{"pmid":"33334823","id":"PMC_33334823","title":"Conserved Gsx2/Ind homeodomain monomer versus homodimer DNA binding defines regulatory outcomes in flies and mice.","date":"2020","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/33334823","citation_count":25,"is_preprint":false},{"pmid":"32122989","id":"PMC_32122989","title":"Physical interactions between Gsx2 and Ascl1 balance progenitor expansion versus neurogenesis in the mouse lateral ganglionic eminence.","date":"2020","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/32122989","citation_count":23,"is_preprint":false},{"pmid":"32162090","id":"PMC_32162090","title":"Transcription factor Hap5 induces gsh2 expression to enhance 2-phenylethanol tolerance and production in an industrial yeast Candida glycerinogenes.","date":"2020","source":"Applied microbiology and biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/32162090","citation_count":23,"is_preprint":false},{"pmid":"20610487","id":"PMC_20610487","title":"Conserved and novel roles for the Gsh2 transcription factor in primary neurogenesis.","date":"2010","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/20610487","citation_count":23,"is_preprint":false},{"pmid":"28814342","id":"PMC_28814342","title":"Septal contributions to olfactory bulb interneuron diversity in the embryonic mouse telencephalon: role of the homeobox gene Gsx2.","date":"2017","source":"Neural development","url":"https://pubmed.ncbi.nlm.nih.gov/28814342","citation_count":21,"is_preprint":false},{"pmid":"19097192","id":"PMC_19097192","title":"Cloning and expression analysis of the anterior parahox genes, Gsh1 and Gsh2 from Xenopus tropicalis.","date":"2009","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/19097192","citation_count":20,"is_preprint":false},{"pmid":"22242181","id":"PMC_22242181","title":"The homeobox gene Gsx2 regulates the self-renewal and differentiation of neural stem cells and the cell fate of postnatal progenitors.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22242181","citation_count":19,"is_preprint":false},{"pmid":"11744393","id":"PMC_11744393","title":"Expression of Ngn1, Ngn2, Cash1, Gsh2 and Sfrp1 in the developing chick telencephalon.","date":"2002","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11744393","citation_count":18,"is_preprint":false},{"pmid":"15295031","id":"PMC_15295031","title":"Striatal neuron differentiation from neurosphere-expanded progenitors depends on Gsh2 expression.","date":"2004","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15295031","citation_count":13,"is_preprint":false},{"pmid":"31412107","id":"PMC_31412107","title":"Agenesis of the putamen and globus pallidus caused by recessive mutations in the homeobox gene GSX2.","date":"2019","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/31412107","citation_count":12,"is_preprint":false},{"pmid":"27618396","id":"PMC_27618396","title":"Characterization of a new Gsx2-cre line in the developing mouse telencephalon.","date":"2016","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/27618396","citation_count":12,"is_preprint":false},{"pmid":"32928905","id":"PMC_32928905","title":"Gsx2 is required for specification of neurons in the inferior olivary nuclei from Ptf1a-expressing neural progenitors in zebrafish.","date":"2020","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/32928905","citation_count":11,"is_preprint":false},{"pmid":"12702282","id":"PMC_12702282","title":"GSH2, a gene encoding gamma-glutamylcysteine synthetase in the methylotrophic yeast Hansenula polymorpha.","date":"2002","source":"FEMS yeast research","url":"https://pubmed.ncbi.nlm.nih.gov/12702282","citation_count":11,"is_preprint":false},{"pmid":"33821423","id":"PMC_33821423","title":"Transcription Factor VAX1 Regulates the Regional Specification of the Subpallium Through Repressing Gsx2.","date":"2021","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/33821423","citation_count":9,"is_preprint":false},{"pmid":"28669025","id":"PMC_28669025","title":"Effects of GSH1 and GSH2 Gene Mutation on Glutathione Synthetases Activity of Saccharomyces cerevisiae.","date":"2017","source":"The protein journal","url":"https://pubmed.ncbi.nlm.nih.gov/28669025","citation_count":7,"is_preprint":false},{"pmid":"26171036","id":"PMC_26171036","title":"GSH2 promoter methylation in pancreatic cancer analyzed by quantitative methylation-specific polymerase chain reaction.","date":"2015","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/26171036","citation_count":6,"is_preprint":false},{"pmid":"38874471","id":"PMC_38874471","title":"Cooperative Gsx2-DNA binding requires DNA bending and a novel Gsx2 homeodomain interface.","date":"2024","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/38874471","citation_count":5,"is_preprint":false},{"pmid":"22986308","id":"PMC_22986308","title":"Preparation of a γ-glutamylcysteine-enriched yeast extract from a newly developed GSH2-deficient strain.","date":"2012","source":"Journal of bioscience and bioengineering","url":"https://pubmed.ncbi.nlm.nih.gov/22986308","citation_count":3,"is_preprint":false},{"pmid":"40832272","id":"PMC_40832272","title":"Mutant IDH silences GSX2 to reprogram neural progenitor cell fate and promote gliomagenesis.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/40832272","citation_count":2,"is_preprint":false},{"pmid":"36184733","id":"PMC_36184733","title":"Gsx2, but not Gsx1, is necessary for early forebrain patterning and long-term survival in zebrafish.","date":"2022","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/36184733","citation_count":2,"is_preprint":false},{"pmid":"12526206","id":"PMC_12526206","title":"[Cloning of the GSH1 and GSH2 genes complementing the defective biosynthesis of glutathione in the methylotrophic yeast Hansenula polymorpha].","date":"2002","source":"Mikrobiologiia","url":"https://pubmed.ncbi.nlm.nih.gov/12526206","citation_count":2,"is_preprint":false},{"pmid":"38106145","id":"PMC_38106145","title":"Cooperative Gsx2-DNA Binding Requires DNA Bending and a Novel Gsx2 Homeodomain Interface.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/38106145","citation_count":1,"is_preprint":false},{"pmid":"39882631","id":"PMC_39882631","title":"Modelling a pathological GSX2 variant that selectively alters DNA binding reveals hypomorphic mouse brain defects.","date":"2025","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/39882631","citation_count":1,"is_preprint":false},{"pmid":"24834720","id":"PMC_24834720","title":"[Transcriptional regulation of the Hansenula polymorpha GSH2 gene in response to cadmium ion treatment].","date":"2014","source":"Ukrainian biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/24834720","citation_count":1,"is_preprint":false},{"pmid":"33039807","id":"PMC_33039807","title":"A CRISPR-strategy for the generation of a detectable fluorescent hESC reporter line (WAe009-A-37) for the subpallial determinant GSX2.","date":"2020","source":"Stem cell research","url":"https://pubmed.ncbi.nlm.nih.gov/33039807","citation_count":1,"is_preprint":false},{"pmid":"41491310","id":"PMC_41491310","title":"Gsx2 regulates oligodendrocyte precursor formation in the zebrafish spinal cord.","date":"2026","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/41491310","citation_count":0,"is_preprint":false},{"pmid":"41279990","id":"PMC_41279990","title":"Gsx2 Regulates Oligodendrocyte Precursor Formation in the Zebrafish Spinal Cord.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41279990","citation_count":0,"is_preprint":false},{"pmid":"41512913","id":"PMC_41512913","title":"An inducible system to study the regulatory functions of GSX2 in human lateral ganglionic eminence-like progenitors.","date":"2026","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/41512913","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.11.11.623106","title":"Orchestrating the Acquisition of Oligodendrocyte Precursor Cell versus Olfactory Bulb Interneuron Fates through  <i>Olig1/2</i>  during Mammalian Cortical Gliogenesis and Gliomagenesis","date":"2024-11-14","source":"bioRxiv","url":"https://doi.org/10.1101/2024.11.11.623106","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.09.20.614077","title":"Evidence that Dmrta2 acts as a transcriptional repressor of  <i>Pax6</i>  in murine cortical progenitors and identification of a mutation crucial for DNA recognition associated with microcephaly in human","date":"2024-09-20","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.20.614077","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.04.30.651564","title":"Gene regulatory networks linked to GABA signalling emerge as relevant for glioblastoma pathogenesis","date":"2025-05-05","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.30.651564","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":25196,"output_tokens":6530,"usd":0.086769,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15458,"output_tokens":5928,"usd":0.112745,"stage2_stop_reason":"end_turn"},"total_usd":0.199514,"stage1_batch_id":"msgbatch_01DUPACZi7AAWwuZiUjseQF4","stage2_batch_id":"msgbatch_018yt7chE3f48PEFtDwtj6AE","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"Gsh-2 encodes a homeodomain protein with an Antennapedia-type homeodomain; a random oligonucleotide selection/PCR amplification procedure defined the target DNA binding sequence as CNAATTAG, establishing its biochemical activity as a sequence-specific DNA-binding transcription factor.\",\n      \"method\": \"Random oligonucleotide selection and PCR amplification (SELEX-type assay)\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro DNA-binding assay defining binding sequence, single lab, single method\",\n      \"pmids\": [\"7619729\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Targeted loss-of-function mutation of Gsh-2 in mice results in a reduced lateral ganglionic eminence, absence of the area postrema, malformed nucleus tractus solitarius, and loss of Dlx2 expression in the LGE, demonstrating that Gsh-2 is required for proper patterning of forebrain and hindbrain structures.\",\n      \"method\": \"Targeted gene knockout in mouse; in situ hybridization; immunohistochemistry\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — germline KO with defined structural and molecular phenotypes, replicated in subsequent studies\",\n      \"pmids\": [\"9398437\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Gsh2 is required to maintain the molecular identity of early striatal progenitors; in Gsh2 loss-of-function mutants, ventral telencephalic regulators Mash1 and Dlx are lost and dorsal regulators Pax6, Neurogenin1, and Neurogenin2 are ectopically expressed in the striatal germinal zone. Genetic epistasis using Pax6;Gsh2 double mutants demonstrated that Pax6 and Gsh2 govern opposing transcriptional programs and mutually repress each other's expression.\",\n      \"method\": \"Single and double loss-of-function mouse mutants; in situ hybridization; genetic epistasis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis with double-mutant rescue, multiple molecular markers, replicated across labs\",\n      \"pmids\": [\"11003836\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Gsh2 is a downstream transcriptional target of Sonic hedgehog signaling in the ventral telencephalon, and its loss results in expansion of dorsal telencephalic markers into the LGE and defects in distinct striatal neuron subpopulations and delay in GABAergic interneuron appearance in the olfactory bulb.\",\n      \"method\": \"Mouse knockout analysis; in situ hybridization; genetic epistasis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO with defined molecular phenotype and Shh pathway placement, single lab\",\n      \"pmids\": [\"11060228\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"In Gsh2 mutants, the dorsal LGE is respecified into a ventral pallium-like structure, while in Pax6 mutants the ventral pallium is respecified into a dLGE-like structure; the early overlapping expression of Pax6 and Gsh2 at the PSB and their complementary loss-of-function phenotypes establish cross-repressive patterning roles at the pallial/subpallial boundary.\",\n      \"method\": \"Analysis of Gsh2 and Pax6 single loss-of-function mouse mutants; in situ hybridization\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — independent replication of cross-repression finding across multiple labs\",\n      \"pmids\": [\"11124115\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Gsh1 compensates for loss of Gsh2 in LGE progenitors; Gsh1 expression expands in Gsh2 null LGE, and Gsh1/2 double mutants show more severe LGE molecular identity disruptions than Gsh2 single mutants. Both Gsh genes together control the size of LGE precursor pools, particularly the subventricular zone population.\",\n      \"method\": \"Single and double homozygous knockout mouse mutants; in situ hybridization\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic epistasis double-mutant analysis with clear dose-dependent phenotype\",\n      \"pmids\": [\"11731457\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Gsh2 and Nkx2.1 act cooperatively (not cross-repressively) to pattern the ventral telencephalon, as shown by double-mutant analysis. However, Gsh2 expressed in the medial ganglionic eminence after E10.5 negatively regulates Nkx2.1-dependent oligodendrocyte specification, based on loss- and gain-of-function analysis.\",\n      \"method\": \"Double-mutant mouse analysis (loss-of-function and gain-of-function); in situ hybridization\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis with double mutants and gain-of-function, single lab\",\n      \"pmids\": [\"12930780\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Gsh2 is required for expression of the retinoic acid synthesis enzyme Raldh3 (Aldh1a3) in the LGE; Gsh2 mutants show markedly reduced retinoid production (measured by retinoid reporter cell assay), and this reduced retinoid production contributes to striatal differentiation defects including fewer DARPP-32 neurons. Exogenous retinoic acid supplementation during neurogenesis significantly increases DARPP-32 expression in Gsh2 mutants.\",\n      \"method\": \"Mouse knockout; retinoid reporter cell assay; in situ hybridization; retinoic acid rescue experiment in vivo\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO phenotype confirmed by reporter assay and RA rescue experiment, multiple orthogonal methods\",\n      \"pmids\": [\"15269172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"In the dorsal spinal cord, Gsh2 is expressed in dI3, dI4, and dI5 progenitors; Gsh2 loss-of-function leads to selective loss of dI3 interneurons with expansion of the dI2 domain and downregulation of Mash1. Overexpression of Gsh2 and Mash1 together ectopically produces dI3 neurons and represses Ngn1, establishing that Gsh2 promotes dI3 fate by repressing Ngn1 and promoting Mash1 expression.\",\n      \"method\": \"Mouse knockout; in situ hybridization; gain-of-function overexpression in neural tube; genetic epistasis with Mash1 mutants\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — KO, GOF, and epistasis with multiple markers, independent validation in same study\",\n      \"pmids\": [\"15930101\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Gsx2 specifies striatal projection neuron identity when expressed at early stages of telencephalic neurogenesis, whereas delayed activation exclusively promotes olfactory bulb interneuron identity; conditional temporal inactivation of Gsx2 causes defects restricted to olfactory bulb interneurons without affecting striatal neurogenesis, demonstrating distinct temporal requirements for these two cell fate decisions.\",\n      \"method\": \"Temporally regulated transgenic gain-of-function; conditional loss-of-function (tamoxifen-inducible Cre); mouse knockout; histological analysis\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — complementary GOF and conditional LOF with temporal control, multiple neuronal subtype readouts\",\n      \"pmids\": [\"19709628\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In Xenopus, Gsh2 mediates transcriptional repression of Dbx1 (identified as a direct target), and cross-repressive interactions between Gsx, Dbx, and Nkx transcription factors pattern the medial CNS at open neural plate stages; the unidirectional interaction hierarchy seen in Drosophila is not conserved in Xenopus.\",\n      \"method\": \"Gain- and loss-of-function manipulation in Xenopus; reporter assays; in situ hybridization\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct target identification with reporter assay, cross-species functional analysis, single lab\",\n      \"pmids\": [\"20610487\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Gsx2 is required for expression of the Helios transcription factor in striatal matrix neurons of the LGE; Helios expression is absent in Gsx2 null mutants but maintained in Ascl1 mutants, placing Gsx2 (together with Dlx1/2) upstream of Helios in an Ascl1-independent striatal progenitor lineage.\",\n      \"method\": \"Immunofluorescence; mouse knockout analysis (Gsx2 null, Dlx1/2 null, Ascl1 null); in situ hybridization\",\n      \"journal\": \"Stem cells and development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — epistasis with multiple mutants, single lab\",\n      \"pmids\": [\"22142223\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Gsx2 controls region-specific activation of neural stem cells (NSCs) in the adult subventricular zone (SVZ); it is expressed in a regionally restricted NSC subset, promotes NSC activation and lineage progression to produce selective olfactory bulb neuron subtypes, and is ectopically induced after brain injury to mediate injury-induced neurogenesis.\",\n      \"method\": \"Mouse conditional knockout; immunohistochemistry; BrdU labeling; injury model; lineage tracing\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — conditional KO with multiple cellular phenotype readouts, injury model, multiple orthogonal methods\",\n      \"pmids\": [\"23723414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Gsx2 suppresses oligodendrocyte precursor cell (OPC) specification in dLGE progenitors; its conditional loss increases OPCs with a concomitant decrease in neurogenesis in the LGE SVZ (E12.5–15.5), and Ascl1 is required for the expansion of these dLGE-derived OPCs in the cortex of Gsx2 mutants. Gain-of-function at late embryonic stages decreases cortical OPCs, confirming that Gsx2 downregulation is required for the neurogenesis-to-oligodendrogenesis transition.\",\n      \"method\": \"Conditional gain-of-function and loss-of-function transgenic mouse; Olig2-Cre conditional inactivation; cell counting; in situ hybridization\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — complementary conditional GOF and LOF, lineage-specific Cre, Ascl1 epistasis, multiple readouts\",\n      \"pmids\": [\"23637331\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Gsx2 loss-of-function rescues overexpression of Ascl1, Hes5, and Olig2 in Dlx1/2 mutants; double Dlx1/2;Gsx2 mutants exacerbate LGE/CGE/septum patterning defects including loss of GAD1 expression; Gsx1 loss from Dlx1/2 mutants partially rescues MGE interneuron migration. These epistasis results place Gsx2 downstream of Dlx1/2 in controlling Ascl1/Notch signaling in the LGE.\",\n      \"method\": \"Compound loss-of-function mouse mutants; in situ hybridization; immunohistochemistry; genetic epistasis\",\n      \"journal\": \"The Journal of comparative neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple compound mutant combinations defining pathway position, multiple molecular readouts\",\n      \"pmids\": [\"23042297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"DMRT3, DMRT5, and EMX2 cooperatively repress Gsx2 at the pallium-subpallium boundary; all three transcription factors directly bind a ventral telencephalon-specific enhancer in the Gsx2 locus (shown by ChIP/binding assays), and loss of Dmrt3;Dmrt5 upregulates Gsx2 in dorsal telencephalon while ectopic Dmrt5 downregulates it ventrally.\",\n      \"method\": \"Single and double knockout mouse mutants; gain-of-function electroporation; ChIP/transcription factor binding assay on Gsx2 enhancer; in situ hybridization\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct enhancer binding demonstrated, multiple KO combinations, GOF/LOF concordance\",\n      \"pmids\": [\"30143575\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Recessive loss-of-function variants in human GSX2 (a truncating p.S9* variant causing complete loss of protein, and a missense p.Q251R variant in the homeodomain) cause basal ganglia agenesis. The Q251R missense variant results in reduced protein expression, impaired homeodomain structural stability, weaker DNA interaction (molecular dynamics), reduced nuclear localization in transfected cells, and altered transcriptional self-regulation with downstream changes in ASCL1 and PAX6 expression in patients' fibroblasts.\",\n      \"method\": \"Whole-exome sequencing; western blot; transfection/nuclear localization assay; molecular dynamics simulation; fibroblast expression studies; whole transcriptome analysis\",\n      \"journal\": \"Brain : a journal of neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — human variant functional characterization, multiple methods but molecular dynamics is computational; nuclear localization directly tested\",\n      \"pmids\": [\"31412107\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Gsx2 gains DNA-binding specificity by forming cooperative homodimers on precisely spaced and oriented bipartite DNA sites; high-resolution genomic binding (ChIP) shows Gsx2 occupies both monomer and homodimer sites in the developing mouse ventral telencephalon. Reporter assays demonstrate that monomer Gsx2 binding represses transcription whereas homodimer binding stimulates gene expression, defining an opposing regulatory outcome dependent on binding site configuration and protein level.\",\n      \"method\": \"High-resolution genomic binding (ChIP-seq); luciferase reporter assays; in vivo Drosophila reporter assays; biochemical DNA-binding assays\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — ChIP-seq, in vitro biochemical assays, in vivo reporter assays, cross-species validation, multiple orthogonal methods\",\n      \"pmids\": [\"33334823\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Gsx2 physically interacts with the bHLH domain of Ascl1, interfering with Ascl1's ability to bind DNA; co-expression of Gsx2 with Ascl1 inhibits neurogenesis in a dose-dependent and Gsx2 DNA-binding-independent manner. Proximity ligation assay in tissue sections demonstrated that Ascl1-Gsx2 interactions are enriched in LGE ventricular zone progenitors, while Ascl1-Tcf3 interactions predominate in the SVZ.\",\n      \"method\": \"Co-immunoprecipitation; luciferase reporter assays; DNA-binding assays; proximity ligation assay in tissue sections; misexpression in dorsal telencephalic progenitors\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — direct protein-protein interaction shown by Co-IP, DNA-binding interference assay, in situ PLA, functional reporter assays, multiple orthogonal methods\",\n      \"pmids\": [\"32122989\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Gsx2 is required for normal forebrain patterning and long-term survival in zebrafish; gsx2 null mutants show significantly reduced expression of distal-less homeobox forebrain patterning genes and fail swim bladder inflation, preventing survival to adulthood.\",\n      \"method\": \"TALEN-mediated zebrafish knockout; in situ hybridization; survival analysis\",\n      \"journal\": \"Developmental dynamics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — KO with molecular phenotype in zebrafish model, single lab\",\n      \"pmids\": [\"36184733\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In zebrafish, gsx2 is required for specification of inferior olivary nucleus (IO) neurons from ptf1a-expressing neural progenitors; gsx2 mutants show strong reduction/loss of IO neurons. Retinoic acid signals positively regulate gsx2 expression and IO neuron development, while Fgf3 and Fgf8a negatively regulate gsx2 expression, placing gsx2 as a mediator of positional signals for IO identity.\",\n      \"method\": \"Zebrafish mutant analysis; in situ hybridization; pharmacological manipulation of RA and FGF signaling\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — KO phenotype with epistasis and signaling pathway placement, single lab, zebrafish model\",\n      \"pmids\": [\"32928905\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Crystal structure of Gsx2 homeodomain bound to DNA revealed that Gsx2 is a monomer in solution and requires DNA for cooperative complex formation; Gsx2 induces a 20° bend in DNA upon binding; a specific protein-protein interface was identified that is required for cooperative homodimerization on DNA; flexible spacer sequences enhance cooperativity on dimer sites. Thermodynamic binding parameters for Gsx2/DNA interactions were defined.\",\n      \"method\": \"X-ray crystallography (high-resolution monomer/DNA structure); biochemical binding assays; biophysical characterization (ITC/SPR); mutagenesis of protein-protein interface\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — crystal structure plus mutagenesis plus biophysical assays, multiple orthogonal methods in single rigorous study\",\n      \"pmids\": [\"38874471\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"The Gsx2Q252R variant (modeling human GSX2Q251R) selectively alters DNA binding; mice carrying this allele exhibit basal ganglia dysgenesis (hypomorphic relative to null), survive to birth with relative sparing of glutamatergic nTS neurons and catecholaminergic A1/C1 and A2/C2 groups, demonstrating that distinct thresholds of Gsx2 DNA-binding activity are required for different neuronal subtypes.\",\n      \"method\": \"Knock-in mouse model; biochemical DNA-binding assays; histological and immunofluorescence analysis; comparison to Gsx2 null mice\",\n      \"journal\": \"Disease models & mechanisms\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — biochemical assay confirming selective DNA-binding defect, in vivo hypomorphic phenotype, comparison to null, multiple neuronal readouts\",\n      \"pmids\": [\"39882631\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Mutant IDH promotes promoter hypermethylation and silencing of Gsx2 in neural progenitor cells, mediating lineage switching from interneuron to oligodendrocyte precursor cell fate; Gsx2 ablation alone recapitulates this NPC fate reprogramming, demonstrating Gsx2 as a required mediator of IDH-mutant glioma initiation.\",\n      \"method\": \"Genetically engineered mouse models; time-resolved single-cell genomics; Gsx2 conditional ablation; epigenomic analysis\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional KO recapitulates oncogene phenotype, single-cell genomics, preprint not yet peer-reviewed\",\n      \"pmids\": [\"40832272\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"In human LGE-like progenitors derived from hESCs with inducible GSX2 expression, transcriptomic/chromatin accessibility/genomic binding studies showed that GSX2 binds both high- and low-accessibility chromatin with varying site preferences, alters chromatin accessibility largely through indirect mechanisms, functions primarily as a transcriptional repressor, and regulates conserved target genes affecting neuronal progenitor maturation and regional specification.\",\n      \"method\": \"Dox-inducible hESC system; RNA-seq; ATAC-seq; ChIP-seq/genomic binding assays\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — multi-omics with transcriptomic, chromatin accessibility and direct genomic binding data, multiple orthogonal methods in human model system\",\n      \"pmids\": [\"41512913\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"In zebrafish spinal cord, Gsx2 is expressed in pre-OPC progenitors and restrains the timing of OPC specification; gsx2 CRISPR loss-of-function mutants initiate OPC formation prematurely and produce excess OPCs without altering oligodendrocyte differentiation, indicating Gsx2 suppresses premature OPC specification in the spinal cord pMN domain.\",\n      \"method\": \"CRISPR/Cas9 knockout zebrafish; single-cell RNA-seq; single-nuclei ATAC-seq; cell counting\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — CRISPR KO with defined cellular phenotype, multi-omics for target prediction, single lab\",\n      \"pmids\": [\"41491310\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GSX2 (Gsh2) is a homeodomain transcription factor that binds DNA both as a monomer (repressing transcription) and as a cooperative homodimer on precisely spaced bipartite sites (activating transcription), inducing a 20° DNA bend; it controls dorsoventral patterning of the ventral telencephalon by cross-repressing Pax6, regulating Raldh3/retinoid production, and physically interacting with and inhibiting the bHLH factor Ascl1 to balance LGE progenitor maintenance versus neurogenesis, while also controlling the timing of OPC specification by suppressing oligodendrogenesis; its downstream target genes include Dlx, Mash1/Ascl1, Ngn1, Dbx1, Raldh3, and Helios, and loss-of-function in humans causes basal ganglia agenesis.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GSX2 (Gsh2) is a sequence-specific homeodomain transcription factor that governs dorsoventral patterning and cell-fate decisions in the developing ventral telencephalon and broader CNS [#0, #1]. It maintains the molecular identity of lateral ganglionic eminence (LGE) progenitors through mutual cross-repression with the dorsal determinant Pax6 at the pallial/subpallial boundary, where loss of Gsx2 respecifies the dorsal LGE toward a ventral pallium-like fate and derepresses Pax6, Neurogenin1/2 [#2, #4]. As a downstream effector of Sonic hedgehog signaling, Gsx2 acts partly redundantly with Gsh1 to set the size of striatal precursor pools [#3, #5], and it drives a striatal differentiation program in part by inducing the retinoic acid synthesis enzyme Raldh3/Aldh1a3, with retinoid supplementation rescuing DARPP-32 neuron deficits in mutants [#7]. Gsx2 controls distinct fates in a temporally and dose-dependent manner: early activity specifies striatal projection neurons while delayed activity promotes olfactory bulb interneuron identity [#9], and downregulation of Gsx2 is required to license the neurogenesis-to-oligodendrogenesis transition, with its loss producing excess OPCs both in the telencephalon and spinal cord [#13, #25]. Mechanistically, Gsx2 acts as a transcriptional repressor at monomeric sites but as an activator when it forms cooperative homodimers on precisely spaced bipartite DNA elements, an interaction that bends DNA ~20\\u00b0 and requires a defined protein\\u2013protein interface revealed by crystallography [#17, #21, #24]. In parallel, Gsx2 physically binds the bHLH domain of the proneural factor Ascl1 to block its DNA binding and inhibit neurogenesis independently of Gsx2's own DNA-binding activity, thereby balancing progenitor maintenance against differentiation [#18]. Recessive loss-of-function variants in human GSX2 cause basal ganglia agenesis, and a homeodomain missense variant modeled in mice produces a hypomorphic DNA-binding defect with selective, threshold-dependent loss of neuronal subtypes [#16, #22].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Established the biochemical identity of Gsh-2 as a sequence-specific DNA-binding factor by defining its preferred target motif, the prerequisite for interpreting all subsequent genetic phenotypes as transcriptional.\",\n      \"evidence\": \"Random oligonucleotide selection/PCR (SELEX-type) defining the CNAATTAG binding sequence for the Antennapedia-type homeodomain\",\n      \"pmids\": [\"7619729\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vitro binding only; no cellular target genes identified\", \"Did not address monomer versus dimer binding modes\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Demonstrated an in vivo developmental requirement by showing that Gsh-2 loss disrupts forebrain and hindbrain structures and abolishes Dlx2 in the LGE, moving the gene from a biochemical entity to a patterning regulator.\",\n      \"evidence\": \"Targeted gene knockout in mouse with in situ hybridization and immunohistochemistry\",\n      \"pmids\": [\"9398437\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct versus indirect regulation of Dlx2 not resolved\", \"Molecular partners not identified\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Defined the core patterning logic of the ventral telencephalon by showing Gsx2 and Pax6 occupy opposing, mutually repressive transcriptional programs and that Gsx2 is a Shh target, situating it within a signaling-to-fate axis.\",\n      \"evidence\": \"Single and double (Pax6;Gsh2) loss-of-function mouse mutants and genetic epistasis; Shh pathway placement\",\n      \"pmids\": [\"11003836\", \"11060228\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether cross-repression is direct at the DNA level not shown\", \"Mechanism of Shh-to-Gsx2 induction unresolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Refined the cross-repression model to the pallial/subpallial boundary and revealed genetic redundancy, showing Gsh1 compensates for Gsh2 loss and that both genes jointly set LGE precursor pool size.\",\n      \"evidence\": \"Gsh2 and Pax6 single mutants and Gsh1/2 single/double knockouts with in situ hybridization\",\n      \"pmids\": [\"11124115\", \"11731457\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Degree of biochemical equivalence between Gsh1 and Gsh2 unknown\", \"Direct targets at the boundary not defined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Distinguished Gsx2's combinatorial logic from simple cross-repression, showing cooperative action with Nkx2.1 in patterning but negative regulation of Nkx2.1-dependent oligodendrocyte specification.\",\n      \"evidence\": \"Double-mutant loss- and gain-of-function mouse analysis with in situ hybridization\",\n      \"pmids\": [\"12930780\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular basis of OPC suppression not defined\", \"Single lab\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Connected Gsx2 to a specific differentiation effector pathway by showing it is required for Raldh3-driven retinoid production, with RA rescue of striatal neuron deficits establishing a causal output.\",\n      \"evidence\": \"Mouse knockout, retinoid reporter cell assay, and in vivo retinoic acid rescue\",\n      \"pmids\": [\"15269172\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Gsx2 directly binds the Raldh3 locus not shown\", \"Other RA-dependent targets not enumerated\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Generalized Gsx2 fate logic beyond the telencephalon to the dorsal spinal cord, defining a repress-Ngn1/promote-Mash1 mechanism for dI3 interneuron specification.\",\n      \"evidence\": \"Mouse knockout, neural tube gain-of-function, and epistasis with Mash1 mutants\",\n      \"pmids\": [\"15930101\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct versus indirect Ngn1 repression not resolved in this context\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Revealed that the same factor produces different fates depending on timing, with early Gsx2 specifying striatal projection neurons and delayed activity producing olfactory bulb interneurons.\",\n      \"evidence\": \"Temporally regulated transgenic gain-of-function and tamoxifen-inducible conditional loss-of-function in mouse\",\n      \"pmids\": [\"19709628\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of temporal competence change not defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identified a direct transcriptional target (Dbx1) and showed the Gsx/Dbx/Nkx cross-repressive network is rewired across species, indicating the network architecture is not strictly conserved.\",\n      \"evidence\": \"Gain/loss-of-function in Xenopus with reporter assays and in situ hybridization\",\n      \"pmids\": [\"20610487\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct binding shown in reporter context only\", \"Single lab, single non-mammalian system\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Placed Gsx2 upstream of Helios in an Ascl1-independent striatal lineage, beginning to dissect parallel branches of the LGE progenitor program.\",\n      \"evidence\": \"Immunofluorescence and epistasis across Gsx2, Dlx1/2, and Ascl1 mutant mice\",\n      \"pmids\": [\"22142223\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct regulation of Helios not demonstrated\", \"Single lab\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Extended Gsx2 function to adult and injury-induced neurogenesis and clarified its role at the neurogenesis-to-oligodendrogenesis switch, embedding it in Dlx1/2 and Ascl1/Notch circuitry.\",\n      \"evidence\": \"Conditional KO, GOF, lineage tracing, injury models, and compound Dlx1/2;Gsx2 and Gsx1 epistasis in mouse\",\n      \"pmids\": [\"23723414\", \"23637331\", \"23042297\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct targets controlling OPC suppression not identified\", \"Mechanism of injury-induced ectopic induction unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identified upstream direct regulators of the Gsx2 locus, showing DMRT3, DMRT5, and EMX2 bind a ventral-telencephalon enhancer to confine Gsx2 expression to the subpallium.\",\n      \"evidence\": \"Single/double mouse knockouts, GOF electroporation, and ChIP/binding assays on the Gsx2 enhancer\",\n      \"pmids\": [\"30143575\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cofactor requirements for enhancer repression not detailed\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Established human disease causation, showing recessive truncating and homeodomain missense GSX2 variants cause basal ganglia agenesis with measurable effects on protein stability, DNA interaction, and nuclear localization.\",\n      \"evidence\": \"Whole-exome sequencing, western blot, nuclear localization assay, molecular dynamics, and patient fibroblast transcriptomics\",\n      \"pmids\": [\"31412107\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"DNA-binding defect of missense allele inferred computationally\", \"Patient cohort limited\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Resolved the dual regulatory logic of Gsx2 mechanistically, showing monomer binding represses while cooperative homodimers on spaced bipartite sites activate, with binding-site configuration and protein level dictating outcome.\",\n      \"evidence\": \"ChIP-seq, luciferase and in vivo Drosophila reporter assays, and biochemical DNA-binding assays\",\n      \"pmids\": [\"33334823\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cofactors discriminating activation versus repression in vivo not identified\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Uncovered a DNA-binding-independent mechanism, demonstrating Gsx2 physically sequesters the Ascl1 bHLH domain to block its DNA binding and inhibit neurogenesis, with spatially distinct Ascl1 partner usage between VZ and SVZ.\",\n      \"evidence\": \"Co-immunoprecipitation, DNA-binding interference, in situ proximity ligation, and reporter/misexpression assays\",\n      \"pmids\": [\"32122989\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry and structural basis of the Gsx2-Ascl1 interface not defined\", \"Reciprocal effect on Gsx2 transcriptional activity not quantified\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Confirmed conserved patterning and identity functions in zebrafish for forebrain Dlx genes and for inferior olivary neurons, with RA promoting and FGF restraining gsx2 expression.\",\n      \"evidence\": \"TALEN and mutant zebrafish analysis with in situ hybridization and pharmacological RA/FGF manipulation\",\n      \"pmids\": [\"36184733\", \"32928905\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct targets in zebrafish not defined\", \"Single lab per study\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Provided the structural basis for cooperative function, showing Gsx2 is monomeric in solution, requires DNA for homodimer assembly through a defined interface, and bends DNA ~20\\u00b0.\",\n      \"evidence\": \"X-ray crystallography of homeodomain/DNA, interface mutagenesis, and ITC/SPR biophysics\",\n      \"pmids\": [\"38874471\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length protein and cofactor complexes not crystallized\", \"Link between bend and transcriptional output not directly tested\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Linked DNA-binding activity to subtype-specific thresholds in vivo, showing a knock-in modeling the human missense variant causes hypomorphic basal ganglia dysgenesis with selective sparing of certain neuron groups.\",\n      \"evidence\": \"Knock-in mouse model with biochemical DNA-binding assays and histological comparison to null mice\",\n      \"pmids\": [\"39882631\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Locus-specific target sensitivities underlying threshold differences not mapped\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Implicated Gsx2 silencing as a required mediator of IDH-mutant glioma initiation, showing promoter hypermethylation reprograms NPCs from interneuron to OPC fate and Gsx2 ablation recapitulates this switch.\",\n      \"evidence\": \"Genetically engineered mouse models, time-resolved single-cell genomics, conditional ablation, and epigenomics (preprint)\",\n      \"pmids\": [\"40832272\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Preprint not yet peer-reviewed\", \"Direct Gsx2 targets controlling the oncogenic fate switch not defined\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Characterized GSX2 chromatin behavior in a human progenitor system, showing it binds both accessible and inaccessible chromatin, acts mainly as a repressor, and alters accessibility largely indirectly.\",\n      \"evidence\": \"Dox-inducible hESC-derived LGE-like progenitors with RNA-seq, ATAC-seq, and ChIP-seq\",\n      \"pmids\": [\"41512913\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of indirect chromatin remodeling unresolved\", \"Cofactors mediating repression not identified\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Confirmed a conserved gliogenic timing role, showing Gsx2 in zebrafish pMN pre-OPC progenitors restrains premature OPC specification without altering differentiation.\",\n      \"evidence\": \"CRISPR/Cas9 zebrafish knockout with single-cell RNA-seq and single-nuclei ATAC-seq\",\n      \"pmids\": [\"41491310\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct targets controlling OPC timing not validated\", \"Single lab\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"It remains unresolved which cofactors and locus-specific features switch Gsx2 between monomeric repression and dimeric activation in vivo, and how these determine subtype-specific thresholds and the oncogenic fate switch.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No identified cofactor that selects activator versus repressor mode in vivo\", \"Genome-wide direct activated versus repressed target sets not fully separated\", \"Mechanism of indirect chromatin accessibility changes unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 2, 17, 24]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 17, 21, 22]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [18]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [16]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [1, 2, 9, 13]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [17, 24]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [8, 12]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"ASCL1\", \"PAX6\", \"GSH1\", \"NKX2.1\", \"DLX1\", \"DLX2\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":7,"faith_total":7,"faith_pct":100.0}}